SecurityCFI / Culp, Inc. (230215105)
IndustryBroadwoven Fabric Mills, Cotton
Institutional Owners85
Institutional Shares13,360,122 - 107.31%
Institutional Value$ 615,768,000 USD
Related CULP / Culp, Inc.

Institutional Stock Ownership and Shareholders

CFI / Culp, Inc. Institutional Ownership

Culp, Inc. (NYSE:CFI) has 85 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 13,360,122 shares. Largest shareholders include Standard Life Aberdeen Plc, Atlantic Trust Group, LLC, Aberdeen Asset Management Plc/uk, Victory Capital Management Inc, Price T Rowe Associates Inc /md/, BlackRock Inc., Dimensional Fund Advisors Lp, Renaissance Technologies LLC, BlackRock Institutional Trust Company, N.A., and Vanguard Group Inc.
Culp, Inc. (NYSE:CFI) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/cfi"><img src="https://images.fintel.io/us-cfi-so.png" alt="CFI / Culp, Inc. Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-04-26 13F-HR SIMPLEX TRADING, LLC 101 176 74.26 3 5 66.67
2018-05-11 13F-HR BNP PARIBAS ARBITRAGE, SA 2,325 2,343 0.77 77,888 71,579 -8.10
2018-05-15 13F-HR Grantham, Mayo, Van Otterloo & Co. LLC 6,700 6,700 0.00 224 205 -8.48
2018-05-08 13F-HR THRIVENT FINANCIAL FOR LUTHERANS 118,097 103,867 -12.05 3,956 3,173 -19.79
2018-05-15 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 8,679 8,542 -1.58 291 260 -10.65
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 920 0 -100.00 31 0 -100.00
2017-02-28 13F-HR HIGH POINT BANK & TRUST CO 4,473 4,473 0.00 133 166 24.81
2018-05-15 13F-HR UBS Group AG 107,999 114,039 5.59 3,618 3,484 -3.70
2018-05-10 13F-HR BESSEMER GROUP INC 19,500 19,500 0.00 653 596 -8.73
2018-05-14 13F-HR ALLIANCEBERNSTEIN L.P. 6,000 6,700 11.67 201 205 1.99
2018-05-10 13F-HR WCM INVESTMENT MANAGEMENT/CA 76,175 75,630 -0.72 2,552 2,310 -9.48
2018-04-20 13F-HR STRS OHIO 20,200 20,200 0.00 676 617 -8.73
2018-05-14 13F-HR TEACHERS ADVISORS INC 19,088 19,088 0.00 639 583 -8.76
2018-05-17 13F-HR Atlantic Trust Group, LLC 1,411,594 1,411,494 -0.01 47,289 43,121 -8.81
2018-05-09 13F-HR EAGLE ASSET MANAGEMENT INC 136,209 156,112 14.61 4,563 4,769 4.51
2018-05-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 13,400 13,400 0.00 449 409 -8.91
2018-05-01 13F-HR WEDGE CAPITAL MANAGEMENT L L P/NC 18,600 21,949 18.01 623 671 7.70
2018-05-09 13F-HR NORTHERN TRUST CORP 140,485 139,392 -0.78 4,707 4,259 -9.52
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 76,006 78,564 3.37 2,546 2,400 -5.73
2018-05-15 13F-HR BARCLAYS PLC 1,941 2,398 23.54 65 74 13.85
2018-05-18 13F-HR Moors & Cabot, Inc. 8,882 8,882 0.00 296 271 -8.45
2018-04-19 13F-HR Endurance Wealth Management, Inc. 0 100 0 3
2018-04-23 13F-HR Advisory Services Network, LLC 0 1,109 0 34
2018-05-15 13F-HR Metlife Investment Advisors, Llc 4,697 4,697 0.00 157 143 -8.92
2017-02-10 13F-HR BlackRock Investment Management, LLC 41,012 40,849 -0.40 1,221 1,518 24.32
2018-05-15 13F-HR TWO SIGMA ADVISERS, LP 20,700 17,500 -15.46 693 535 -22.80
2018-05-15 13F-HR METROPOLITAN LIFE INSURANCE CO/NY 4,099 4,099 0.00 137 125,225 91,305.11
2017-08-10 13F-HR ABERDEEN ASSET MANAGEMENT PLC/UK 1,273,928 1,367,922 7.38 39,747 44,458 11.85
2018-05-15 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 17,281 16,684 -3.45 579 510 -11.92
2017-02-10 13F-HR BlackRock Japan Co. Ltd 1,398 1,152 -17.60 42 43 2.38
2018-05-15 13F-HR DEUTSCHE BANK AG\ 24,418 12,253 -49.82 816 372 -54.41
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 18,926 18,718 -1.10 635 572 -9.92
2018-05-14 13F-HR AMERIPRISE FINANCIAL INC 32,209 28,621 -11.14 1,079 874 -19.00
2018-05-07 13F-HR AMERICAN INTERNATIONAL GROUP INC 7,379 7,003 -5.10 247 214 -13.36
2017-02-10 13F-HR BlackRock Fund Advisors 294,292 340,246 15.62 8,761 12,640 44.28
2018-05-17 13F-HR Legal & General Group Plc 3,067 2,067 -32.61 101 63 -37.62
2018-05-15 13F-HR JOHNSON INVESTMENT COUNSEL INC 23,000 26,120 13.57 770 797 3.51
2018-05-10 13F-HR GREAT WEST LIFE ASSURANCE CO /CAN/ 134 4
2018-05-16 13F-HR Foundry Partners, LLC 46,695 47,195 1.07 1,564 1,442 -7.80
2018-05-09 13F-HR FEDERATED INVESTORS INC /PA/ 297 96 -67.68 10 3 -70.00
2018-05-02 13F-HR RHUMBLINE ADVISERS 9,947 9,672 -2.76 333 295 -11.41
2018-05-14 13F-HR PRICE T ROWE ASSOCIATES INC /MD/ 1,110,007 1,101,204 -0.79 37,185 33,642 -9.53
2018-05-07 13F-HR MUFG Americas Holdings Corp 81 0 -100.00 3 0 -100.00
2018-05-14 13F-HR Renaissance Technologies LLC 620,200 625,100 0.79 20,777 19,097 -8.09
2018-05-14 13F-HR BROWN ADVISORY INC 168,706 47,080 -72.09 5,651 1,438 -74.55
2017-02-14 13F-HR KEELEY ASSET MANAGEMENT CORP 76,651 72,381 -5.57 2,282 2,689 17.84
2018-05-08 13F-HR US BANCORP \DE\ 1,824 1,871 2.58 61 57 -6.56
2018-05-15 13F-HR Advisor Group, Inc. 561 0 -100.00 19 0 -100.00
2018-05-15 13F-HR PANAGORA ASSET MANAGEMENT INC 28,488 36,338 27.56 954 1,110 16.35
2018-04-10 13F-HR NISA INVESTMENT ADVISORS L.L.C. 275 8
2018-05-11 13F-HR Delpha Capital Management, Llc 76 0 -100.00 3 0 -100.00
2018-04-23 13F-HR FIRST TRUST ADVISORS LP 9,355 10,033 7.25 313 307 -1.92
2018-05-14 13F-HR Nuveen Asset Management, LLC 347,156 343,295 -1.11 11,630 10,488 -9.82
2018-05-11 13F-HR DIMENSIONAL FUND ADVISORS LP 733,426 734,910 0.20 24,569 22,452 -8.62
2018-05-11 13F-HR ISTHMUS PARTNERS, LLC 24,646 26,120 5.98 826 798 -3.39
2018-05-14 13F-HR MORGAN STANLEY 82,164 80,193 -2.40 2,752 2,449 -11.01
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 52,433 54,786 4.49 1,756 1,674 -4.67
2018-05-15 13F-HR D. E. Shaw & Co., Inc. 25,511 23,398 -8.28 855 715 -16.37
2018-05-15 13F-HR RBF Capital, LLC 10,000 10,000 0.00 335 306 -8.66
2018-05-15 13F-HR AQR CAPITAL MANAGEMENT LLC 12,067 10,878 -9.85 404 332 -17.82
2018-05-10 13F-HR JP Morgan Chase & Co 2,363 2,206 -6.64 79 67 -15.19
2018-05-15 13F-HR Invesco Ltd. 12,527 15,335 22.42 420 468 11.43
2018-04-04 13F-HR CONFLUENCE INVESTMENT MANAGEMENT LLC 132,492 139,357 5.18 4,439 4,258 -4.08
2018-05-15 13F-HR Ameritas Investment Partners, Inc. 785 785 0.00 26 24 -7.69
2017-02-10 13F-HR BlackRock Group LTD 12,080 12,080 0.00 360 449 24.72
2018-05-14 13F-HR RAYMOND JAMES & ASSOCIATES 8,528 8,607 0.93 286 263 -8.04
2017-02-10 13F-HR BlackRock Advisors LLC 199,601 193,997 -2.81 5,942 7,207 21.29
2018-05-15 13F-HR Keeley-Teton Advisors, LLC 38,110 56,277 47.67 1,277 1,719 34.61
2018-05-11 13F-HR MARTINGALE ASSET MANAGEMENT L P 45,809 43,414 -5.23 1,535 1,327 -13.55
2018-05-15 13F-HR Parallax Volatility Advisers, L.P. 1,680 0 -100.00 56 0 -100.00
2018-05-14 13F-HR Royce & Associates LLC 128,857 126,158 -2.09 4,317 3,854 -10.73
2018-05-10 13F-HR THOMSON HORSTMANN & BRYANT INC 213,430 216,649 1.51 7,149 6,618 -7.43
2018-05-04 13F-HR VICTORY CAPITAL MANAGEMENT INC 1,133,450 1,261,345 11.28 37,971 38,534 1.48
2018-05-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 26,634 26,971 1.27 892 824 -7.62
2017-10-26 13F-HR Acrospire Investment Management LLC 1,093 0 -100.00 36 0 -100.00
2018-05-11 13F-HR GSA CAPITAL PARTNERS LLP 19,862 0 -100.00 665 0 -100.00
2018-05-15 13F-HR Voya Investment Management LLC 6,414 0 -100.00 215 0 -100.00
2018-05-15 13F-HR KEYBANK NATIONAL ASSOCIATION/OH 25,375 25,950 2.27 850 793 -6.71
2018-05-11 13F-HR CITIGROUP INC 8,836 4,407 -50.12 296 135 -54.39
2018-05-07 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 23,815 23,815 0.00 798 728 -8.77
2018-05-14 13F-HR PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 69,676 69,676 0.00 2,334 2,129 -8.78
2018-05-15 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 0 200 0 6
2018-05-11 13F-HR Russell Investments Group, Ltd. 3,450 4,257 23.39 112 130 16.07
2018-05-15 13F-HR VANGUARD GROUP INC 467,839 463,694 -0.89 15,673 14,166 -9.62
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC 15,948 13,625 -14.57 534 416 -22.10
2018-05-14 13F-HR Stone Ridge Asset Management LLC 9,748 9,748 0.00 327 298 -8.87
2018-05-15 13F-HR Standard Life Aberdeen Plc 1,546,239 1,468,924 -5.00 51,837 44,876 -13.43
2018-05-15 13F-HR Bank of New York Mellon Corp 91,159 92,672 1.66 3,054 2,831 -7.30
2018-05-15 13F-HR QS Investors, LLC 2,217 2,406 8.53 74 74 0.00
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 59,180 64,485 8.96 1,983 1,969 -0.71
2018-05-15 13F-HR STATE STREET CORP 194,490 202,264 4.00 6,519 6,181 -5.18
2018-05-09 13F-HR BlackRock Inc. 895,900 874,664 -2.37 30,013 26,722 -10.97
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 583,665 598,606 2.56 17,376 22,238 27.98

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

11h - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

Related News Stories

Culp Inc's (CULP) CEO Frank Saxon on Q4 2018 Results - Earnings Call Transcript

2018-06-14 seekingalpha
Good day and welcome to the Culp’s Fourth Quarter 2018 Earnings Conference Call. Today's conference is being recorded. At this time, for opening remarks and instructions, I'd like to turn the call over to Ms. Dru Anderson. Please go ahead ma’am. (2-0)

CUSIP: 230215105